NCT05630131View on ClinicalTrials.gov

ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

Active, not recruitingOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions

Bladder CancerMuscle-Invasive Bladder Carcinoma

Trial Locations (1)

27599

North Carolina Cancer Hospital (UNC), Chapel Hill

All Listed Sponsors

lead

UNC Lineberger Comprehensive Cancer Center

OTHER